HealthcarePapers 4(3) April 2004 : 60-66.doi:10.12927/hcpap..16878
The lead paper provides a helpful review of the implications of last-dollar and first-dollar reimbursement of pharmaceuticals. Yet, the issue is extremely complex, and there are no easy solutions. Ultimately, the benefits and costs of drugs will force us as a society to make some very hard decisions about fundamental human values such as access, equity and affordability.
Be the first to comment on this!
This article is for subscribers only. To view the entire article
Note: Please enter a display name. Your email address will not be publically displayed